UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer.
Xiao J, Sun F, Wang YN, Liu B, Zhou P, Wang FX, Zhou HF, Ge Y, Yue TT, Luo JH, Yang CL, Rong SJ, Xiong ZZ, Ma S, Zhang Q, Xun Y, Yang CG, Luan Y, Wang SG, Wang CY, Wang ZH.
Xiao J, et al. Among authors: xun y.
J Clin Invest. 2023 Feb 15;133(4):e158352. doi: 10.1172/JCI158352.
J Clin Invest. 2023.
PMID: 36626227
Free PMC article.